Yili Test GCHb multi-function monitoring system for blood glucose/cholesterol/heme - Taiwan Registration 4d94f472bf86ddf3c15561ddb5c6e6bb
Access comprehensive regulatory information for Yili Test GCHb multi-function monitoring system for blood glucose/cholesterol/heme in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 4d94f472bf86ddf3c15561ddb5c6e6bb and manufactured by BIOPTIK TECHNOLOGY, INC.. The authorized representative in Taiwan is BIOPTIK TECHNOLOGY, INC..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
4d94f472bf86ddf3c15561ddb5c6e6bb
DHY00500330101
Product Details
This product is only for in vitro testing, measured with fresh fingertip microvascular whole blood to quantify blood sugar, cholesterol and heme content. This product can be used by self-testing and healthcare professionals, but is not intended for testing of newborns. Performance change: This product is only for in vitro testing, and blood glucose and heme content are quantified by measuring fresh fingertip microvascular whole blood. This product is intended for use by healthcare professionals only, but is not intended for testing in newborns.
A Clinical chemistry and clinical toxicology
A.1345 Glucose Test System
Domestic
Dates and Status
Jun 13, 2011
Jun 13, 2026